Development, cytokine profile and function of human interleukin 17-producing helper T cells

Nature Immunology

Volumn 8, Issue 9, 2007, Pages 950-957

  Wilson, Nicholas J ^a   Boniface, Katia ^a   Chan, Jason R ^a,c   McKenzie, Brent S ^a   Blumenschein, Wendy M ^a   Mattson, Jeanine D ^a   Basham, Beth ^a   Smith, Kathleen ^a   Chen, Taiying ^a   Morel, Franck ^b   Lecron, Jean Claude ^b   Kastelein, Robert A ^a   Cua, Daniel J ^a   McClanahan, Terrill K ^a   Bowman, Edward P ^a   Malefyt, Rene de Waal ^a  

^a Schering Plough Biopharma ^*  (United States)

^b UNIVERSITÉ DE POITIERS   (France)

^c Entelos Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; CELL MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 26; INTERLEUKIN RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TRANSCRIPTION FACTOR;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DATA ANALYSIS; DENDRITIC CELL; EPITHELIUM CELL; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; KERATINOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PSORIASIS;

ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-23; POLYMERASE CHAIN REACTION; PSORIASIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 34548133583     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1497     Document Type: Article

References (50)

1. Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
2. Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787-793 (1996).
3. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003).
4. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
5. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13, 139-145 (2007).
6. H-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350 (2007).
7. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 648-651 (2007).
8. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
9. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
10. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
11. Murphy, C.A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
12. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
13. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116 1310-1316 (2006).
14. Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725 (2000).
15. H17 lineage. Nature 441, 231-234 (2006).
16. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 179-189 (2006).
17. H17 and regulatory T cells. Nature 441, 235-238 (2006).
18. + T helper cells. Cell 126, 1121-1133 (2006).
19. Sutton, C., Brereton, C., Keogh, B., Mills, K.H. & Lavelle, E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006).
20. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936 (2006).
21. Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 (2006).
22. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
23. Chan, J.R. et al. L-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
24. Schon, M.P. & Boehncke, W.H. Pseriasis. N. Engl. Med. 352, 1899-1912 (2005).
25. Harder, J. & Schroder, J.M. Psoriatic scales: A promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 77, 476-486 (2005).
26. Selsted, M.E. & Ouellette, A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6, 551-557 (2005).
27. Lee, E. et al. Increased expression of interleukin-23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199, 125-130 (2004).
28. Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006).
29. Teunissen, M.B., Koomen, C.W., de Waal Malefyt, R., Wierenga, E.A. & Bos, J.D. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111, 645-649 (1998).
30. Boniface, K. et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695-3702 (2005).
31. Hor, S. et al. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J. Biol. Chem. 279, 33343-33351 (2004).
32. Wiekowski, M.T. et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J. Immunol. 166, 7563-7570 (2001).
33. Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290 (2007).
34. Krueger, G.G. et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580-592 (2007).
35. Nagalakshmi, M.L., Murphy, E., McClanahan, T & de Waal Malefyt, R. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4 577-592 (2004).
36. Brown, K.L. & Hancock, R.E. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18, 24-30 (2006).
37. Gurney, A.L. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 4, 669-677 (2004).
38. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (1996).
39. Sheikh, F. et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 172, 2006-2010 (2004).
40. Hoover, D.M. et al. The structure of human macrophage inflammatory protein-3α/CCL-20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human β-defensins. J. Biol. Chem. 277, 37647-37654 (2002).
41. Yang, D. et al. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leukoc. Biol. 74, 448-455 (2003).
42. Iwasaki, A. & Kelsall, B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191, 1381-1394 (2000).
43. Vanbervliet, B. et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: Possible role at inflamed epithelial surfaces. Eur. J. Immunol. 32, 231-242 (2002).
44. Liao, F. et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 α. J. Immunol. 162, 186-194 (1999).
45. Yang, D. et al. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528 (1999).
46. Stark, M.A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285-294 (2005).
47. Happel, K. I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
48. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527 (2001).
49. Kleinschek, M.A. et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176, 1098-1106 (2006).
50. Yssel, H.S. & Spits, H. in Current Protocols in Immunology 7-19 (Green and Wiley, New York, 2001).